Some Critical Episodes in the Progress of Medical Innovation: An Anglo-American Perspective
The central concern of this paper is to show that medical innovations have depended heavily on breaking down barriers that have long prevailed in the academic world, in the form of disciplinary boundaries that have coalesced into separate departments. In the longer run, this sharp distinction between Life Sciences and Physical Sciences may be the basis for excessively narrow and inappropriate policy recommendations. Some of the biggest breakthroughs in the Life Sciences came from the Physical Sciences.
|Date of creation:||Nov 2008|
|Date of revision:|
|Contact details of provider:|| Postal: 366 Galvez Street, Stanford, California 94305-6015|
Phone: (650) 725-1874
Fax: (650) 723-8611
Web page: http://siepr.stanford.edu
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Lynne G. Zucker & Michael R. Darby & Marilynn B. Brewer, 1994. "Intellectual Capital and the Birth of U.S. Biotechnology Enterprises," NBER Working Papers 4653, National Bureau of Economic Research, Inc.
When requesting a correction, please mention this item's handle: RePEc:sip:dpaper:08-008. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Anne Shor)
If references are entirely missing, you can add them using this form.